deltatrials
Completed PHASE2/PHASE3 NCT00607178

The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases

Randomized, Single-Blind, Placebo-Controlled Study of Influenza Vaccine in Preventing Cardiovascular Events in Post-Myocardial Infarction Patients and in Those With Stable Angina Pectoris

Sponsor: Shahid Beheshti University of Medical Sciences

Conditions Coronary Artery Diseases Myocardial Infarction Stable Angina
Interventions influenza vaccine placebo for influenza vaccine
Updated 6 times since 2017 Last updated: Jan 20, 2009 Started: Jan 31, 2008 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

Listed as NCT00607178, this PHASE2/PHASE3 trial focuses on Coronary Artery Diseases and Myocardial Infarction and remains completed. Sponsored by Shahid Beheshti University of Medical Sciences, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shahid Beheshti University of Medical Sciences
Data source: Shahid Beheshti University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tehran, Iran